ArticleVascular health and risk management2011

Candesartan cilexetil/hydrochlorothiazide combination treatment versus high-dose candesartan cilexetil monotherapy in patients with mild to moderate cardiovascular risk (CHILI Triple T).

Gerd Bönner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.